These confounding observations indicate that the metabolic abnormalities observed with whole body modulation of ANGPTL4 make assessment of the role of ANGPTL4 in atherosclerosis development complicated and thus, tissue-specific ANGPTL4 modulation might mitigate these systemic effects in multiple organs and provide meaningful data. The gene discussed is ANGPTL4; the disease is atherosclerosis.